BCPC
BALCHEM CORP
NASDAQ · Basic Materials · Chemicals - Specialty · US
$175.51
+0.52%Year over year
Reported trailing growth
- Revenue
- +9.4%
- EBITDA
- +10.4%
- EBIT
- +16.1%
- EPS
- +16.1%
- Free cash flow
- +28.5%
- Operating cash flow
- +11.0%
Forward estimates
Based on analyst estimates
- Revenue
- +6.2%
- EBITDA
- +5.5%
- EPS
- +5.6%
Three-year CAGR
- Revenue
- +3.2%
- EBITDA
- +9.2%
- EBIT
- +14.6%
- Net income
- +13.7%
- EPS
- +13.4%
- Free cash flow
- +25.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026